252 related articles for article (PubMed ID: 433214)
1. [Skin reactions of delayed hypersensitivity in melanoblastoma].
Ryzhkov VI; Potapenkova LS; Korosteleva TA; Khachaturian LM
Vopr Onkol; 1979; 25(4):3-6. PubMed ID: 433214
[TBL] [Abstract][Full Text] [Related]
2. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
3. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of the level of humoral cytotoxins and delayed hypersensitivity skin reactions with survival of patients with melanoma of the skin].
Korosteleva TA; Vagner RI; Veresova OV; Potapenkova LS
Vopr Onkol; 1983; 29(4):38-40. PubMed ID: 6858049
[TBL] [Abstract][Full Text] [Related]
5. Delayed hypersensitivity in patients with bronchial carcinoma.
Pauwels R; van der Straeten M
Scand J Respir Dis; 1975 Sep; 56(3):160-4. PubMed ID: 1162307
[TBL] [Abstract][Full Text] [Related]
6. Delayed hypersensitivity reaction in patients with bone and soft tissue sarcoma.
Shinohara N; Fukuma H; Nishio A
Nihon Seikeigeka Gakkai Zasshi; 1979 Jun; 53(6):705-11. PubMed ID: 490017
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
[TBL] [Abstract][Full Text] [Related]
8. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
9. [Skin tests of delayed hypersensitivity (tuberculin, DNCB) in the immunologic study of patients with primary cancer of the lung].
Bariffi F; Illiano A; Tranfa CM; Del Prato B
Arch Monaldi; 1978; 33(4):239-50. PubMed ID: 756707
[No Abstract] [Full Text] [Related]
10. [Decrease in immunoreactivity in melanoma. Analysis of DNCB tests in the literature].
Remy W; Dorn R; Ulm K; Mayerhausen W
Z Hautkr; 1986 Dec; 61(24):1767-77. PubMed ID: 3825218
[TBL] [Abstract][Full Text] [Related]
11. [Delayed skin hypersensitivity to 2,4-dinitrochlorobenzene (DNCB) in patients with bronchial carcinoma].
Ruszel KB
Wiad Lek; 1978 Oct; 31(19):1341-4. PubMed ID: 716404
[No Abstract] [Full Text] [Related]
12. Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
Rangel DM; Golub SH; Morton DL
Surgery; 1977 Aug; 82(2):224-32. PubMed ID: 877866
[TBL] [Abstract][Full Text] [Related]
13. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
Bolton PM
Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933
[No Abstract] [Full Text] [Related]
14. [DNCB-skin specimens for immunodiagnosis].
Sinn W
Z Gesamte Inn Med; 1981 Sep; 36(17):602-7. PubMed ID: 7345806
[TBL] [Abstract][Full Text] [Related]
15. [2,4-dinitrochlorobenzene skin test as an index of the primary cellular immunological response in skin diseases and syphilis].
Fedotov VP; Lesnitskiĭ AI; Logunov VP; Manuĭlova LA; Zheliaz EV
Vestn Dermatol Venerol; 1981; (10):7-12. PubMed ID: 7303876
[No Abstract] [Full Text] [Related]
16. [Experimental induction of the delayed reaction as immunologica indicator (in dermatoses, tumors, immunosuppression)].
Remy W; Stüttgen G
Allerg Immunol (Leipz); 1972; 18(2):97-104. PubMed ID: 4266967
[No Abstract] [Full Text] [Related]
17. [Delayed hypersensitivity in pediatric patients with cancer].
Rivera Luna R; Munford DM; Wilbur JR
Bol Med Hosp Infant Mex; 1977; 34(6):11-71. PubMed ID: 588329
[TBL] [Abstract][Full Text] [Related]
18. [A study on immunological skin reactions in patients with active pulmonary tuberculosis. Clinical significance of the reduction of DNCB reaction in patients with active pulmonary tuberculosis].
Ishibashi J
Kekkaku; 1982 Dec; 57(12):665-70. PubMed ID: 7182645
[No Abstract] [Full Text] [Related]
19. [Cellular immunity indices in primary cancer and nontumorous diseases of the liver].
Komissarenko VG; Shaĭn AA
Vopr Onkol; 1981; 27(1):36-40. PubMed ID: 6969949
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous, cellular immunity in malignant melanoma].
Kehrer HC
Wien Klin Wochenschr; 1991; 103(13):396-7. PubMed ID: 1897233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
